Fidelity SPDR Advertisement
Home > Boards > US OTC > Biotechs >

Amarantus BioScience Holdings, Inc. (AMBS)

AMBS RSS Feed
Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator dshade, r00kie, joboggi, Sir Francelote, Rosym
Search This Board:
Last Post: 9/21/2014 1:57:01 AM - Followers: 720 - Board type: Free - Posts Today: 2

   

Amarantus BioScience Holdings, Inc.

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The company has licensed Eltoprazine, a Phase 2B ready Parkinsons Levadopa induced Dyskinesia. The company has an exclusive worldwide license to the Lymphocyte Proliferation test ("LymPro Test®") for Alzheimer's Disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property rights for the diagnosis of Parkinson's Disease ("NuroPro") and the discovery of neurotrophic facotrs ("PhenoGuard"). For further information, please visit www.Amarantus.comor connect with the company on FacebookTwitter, LinkedIn & Google+

 

 
                       


 
PRESS RELEASES & NEWS ARTICLES


Fundamental Milestones Ahead: Up-Listing from Strength
Thrursday, Sept. 18th 2014   12:30 p.m.
Amarantus Provides Program Update on Phase 2b Eltoprazine for Parkinson's Disease and Adult ADHD
Sept 17, 2014    8:00 a.m.
Amarantus Completes Enrollment of 72 Patient LP-002 Clinical Study for Alzheimer's Blood Diagnostic LymPro Test(R)
Sept 12, 2014   10:30 a.m.
Amarantus to Present Orphan Ocular Data at Targeting Ocular Disorders Conference 2014
Sept 10, 2014   1:00 p.m.
Amarantus Announces Positive MANF Ocular Toxicology Data
Sept. 9, 2014   8:31 a.m.
Amarantus to Present at Sachs Associates 14th Annual Biotech in Europe Forum for Global Partnering and Investment

Sept 4, 2014   9:00 a.m.
Initiating Studies for CLIA Launch at Icon Central Laboratories
September 2nd, 2014   8:00 am
Amarantus BioScience Holdings, Inc. - "Initiating Studies for CLIA Launch at Icon Central Laboratories"
Sept 2, 2014   8:26 a.m.
Amarantus Initiates CLIA Development of Alzheimer's Blood Diagnostic LymPro Test(R) at ICON Central Laboratories
Sept 2, 2014   6:00 a.m. 
Amarantus Appoints Iain Ross to Board of Directors
Aug. 29, 2014   7:57 a.m. 
Amarantus Reports Second Quarter 2014 Financial Results, Announces Business Update Call
Aug. 27, 2014   9:00 a.m  
Amarantus to Present at Upcoming Investor Conferences
Aug. 19, 2014   8:42 A.M. 
Amarantus Exercises Option to License Intellectual Property From University of Miami Bascom Palmer Eye Institute for Use of MANF in Retinal Disorders
Aug. 15, 2014   8:11 A.M. 
Amarantus BioScience Holdings, Inc. "Preparing Amarantus for the Up-list in 2H-14: Capital Markets Strategy"
Aug. 11, 2014   8:03 a.m. 
Amarantus Enters Into Research Collaboration With the Buck Institute for Research on Aging for MANF
Aug. 11, 2014   8:01 A.M. ET

 

      

SNNLive - Amarantus BioScience Holdings, Inc.
Published on June 21, 2014

SNNLive - Amarantus BioScience Holdings, Inc.
Published on May 21, 2014

 

                             
                                              

Medical Dictionary (some often-used terms in AMBS PRs)

The substania nigra is an area of pigmented cells in the midbrain which is responsible for producing the neurotransmitter dopamine. This section of the brain plays an important role in the control of movement, and it also appears to interact in the process of addiction, as well. If you view a brain in cross-section, the substantia nigra is located in the midbrain, right at the tip of the brainstem.
The striatum is also called the striate body. It includes the caudate nucleus and the lentiform nucleus. The term striatum (striate) refers to the layered appearance of bands of gray matter that course from one of these nuclei to the other and represent the connections between them.
In living tissues, reinnervation describes the process by which post-synaptic neurons form new synapses or increase existing synaptic efficacy in order to compensate for a lack of pre-synaptic input from dead or otherwise dysfunctional pre-synaptic neurons.

Glial cell-derived neurotrophic factor, also known as GDNF is a protein that, in humans, is encoded by the GDNF gene.[1] GDNF is a small protein that potently promotes the survival of many types of neurons.[2
Myocardial infarction (MI) or acute myocardial infarction (AMI), commonly known as a heart attack


 

  Pertinent Terms of Service
 

A. Is unlawful, threatening, abusive, harassing, defamatory, libelous, vulgar, hateful, deceptive, fraudulent, invasive of another's privacy, tortious, contains explicit or graphic descriptions or accounts of sexual acts (including but not limited to sexual language of a violent or threatening nature directed at another individual or group of individuals), or otherwise violates our rules or policies; This includes signatures as well. 
B. Attacks, verbally or otherwise, any other user, the website, any non-public figure, or any agents or employees of iHub; This includes signatures as well.
C. Victimizes, harasses, degrades, or intimidates an individual or group of individuals on the basis of religion, gender, sexual orientation, race, ethnicity, age, or disability; This includes signatures as well.

 A reminder, if your post is removed and you think it should be restored go to mailbox, and then click on removed posts, and follow the directions. Post that talk about other members, or other companies violate the TOS. Those posts are routinely deleted. It is easy to talk about AMBS without talking about the posters or in most cases, other companies and products.



 
 

      Mr. Commissiong made a presentation on Sept. 12/14 at the Aegis Capital 2014                          Healthcare and Technology Conference at web cast live at 10:00 AM PT and
               available at http://wsw.com/webcast/aegis/ambs/ .
 
  

 

 

   Amarantus Bioscience Holdings, Inc. (otcqb:AMBS), a biotechnology company focused on the development of diagnostic and therapeutic interventions for Alzheimer's disease, Parkinson's disease and
orphan ophthalmological disorders, announced that Gerald E. Commissiong, President and CEO, is scheduled
to present at the 14th Annual Biotech in Europe Forum at the Congress Center in Basel, Switzerland. 
The presentation is scheduled for Wednesday, October 1st at 11:45 AM in the Darwin Room Mr. Commissiong's presentation will be web cast live and available on the company's web site at www.amarantus.com.

Additional information about the conference may be found at www.sachsforum.com. Attendees who wish to meet with management one on one may contact our Investor Relations department at ir@amarantus.com

angel  Dr. Roman Urfer, Chief Development Officer at NeuroAssets Sarl, will be presenting efficacy data for MANF in an undisclosed orphan ocular indication at Targeting Ocular Disorders 2014NeuroAssets is a Swiss-based neuroscience-focused consulting firm engaged by Amarantus to support the translational development of MANF. 
Dr. Urfer's presentation will be made at 3:40pm ET on October 6th, 2014 at the Westin Boston Waterfront Market in Boston, MA.


smiley  AMBS expect to complete the agreement with Big Pharma, partner by the end of the summer.



 
 
    
       

 

Company Information

Investor Relations

Transfer Agent

Amarantus BioScience Holdings, Inc.
c/o Janssen Labs @ QB3
953 Indiana Street
San Francisco, CA 94107

c/o ICS Corporate Services SA
29 quai du Mont Blanc
CH-1201 Geneva
Switzerland

info@amarantus.com
pr@amarantus.com


Phone: (408) 737-2734
Fax: (408) 852-4427

Aimee Boutcher
Director of Investor Relations
Amarantus BioScience Holdings, Inc
.

408-737-2734 x101
ir@amarantus.com








 
VStock Transfer, LLC
77 Spruce Street, Suite 201
Cedarhurst, NY 11516

Attn: Allison Niccols


Phone: 212-828-8436
Toll-Free: 855-9VSTOCK
Fax: 646-536-3179

           
info@vstocktransfer.com

www.VStockTransfer.com 


 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS
Current Price
Volume:
Bid Ask Day's Range
Wiki
AMBS News: Initial Statement of Beneficial Ownership (3) 09/19/2014 04:15:04 PM
AMBS News: Initial Statement of Beneficial Ownership (3) 09/15/2014 05:00:14 PM
AMBS News: Initial Statement of Beneficial Ownership (3) 09/04/2014 06:56:01 PM
AMBS News: Initial Statement of Beneficial Ownership (3) 09/04/2014 04:07:28 PM
AMBS News: Current Report Filing (8-k) 09/02/2014 05:26:11 PM
PostSubject
#108320  Sticky Note New or Potential investors in AMBS r00kie 09/08/14 04:02:27 PM
#108317  Sticky Note http://cdn2.hubspot.net/hub/150154/file-1570257974-pdf/AMARANTUS_AMBS-Executive- zoomboom 09/08/14 09:42:50 AM
#107220  Sticky Note About Amarantus BioScience, Inc. Rosym 08/07/14 04:32:28 PM
#104968  Sticky Note MJFF is firm with their notion that NFs joboggi 07/17/14 02:01:07 AM
#108629   Its been said that Solantey sold his million michelebucks 09/21/14 01:57:01 AM
#108628   "Obviously I didn't have a clue about where veeets 09/21/14 12:42:10 AM
#108627   That is correct to say that 2people cant xxxxxl 09/20/14 11:17:16 PM
#108626   No one or two people can affect a joboggi 09/20/14 07:29:11 PM
#108625   Just a reminder: Message board posting is for Salexander1 09/20/14 06:48:21 PM
#108623   Sorry, it not going to happen. The pps Rosym 09/20/14 02:58:20 PM
#108622   My prediction from more than a month ago. Solantey 09/20/14 01:52:08 PM
#108621   Another post clearly intended to deceive every one. Solantey 09/20/14 01:48:45 PM
#108620   I was definitely being deceptive when I posted Solantey 09/20/14 01:47:04 PM
#108619   A Financial re-engineering announcement can change everyone's perceptions Salexander1 09/20/14 01:16:58 PM
#108616   Again, telling a falshood million times doesn't make xxxxxl 09/20/14 11:55:05 AM
#108615   I will agree with lower, no doubt about joboggi 09/20/14 09:40:50 AM
#108614   Unless Gerald has substantially good news to present Solantey 09/20/14 09:17:31 AM
#108613   This says they are not going to uplist joboggi 09/20/14 08:43:52 AM
#108612   Joboggi I am not interested in the chart Rosym 09/20/14 08:10:20 AM
#108611   http://stockcharts.com/freecharts/gallery.html?s=Ambs This chart tells the st joboggi 09/20/14 06:04:35 AM
#108609   There was a time i put your perspective shamalam 09/19/14 09:13:33 PM
#108608   You are hoping to get lower share price. Rosym 09/19/14 08:37:41 PM
#108606   The share price was near .20 and headed Solantey 09/19/14 07:29:20 PM
#108605   Heuh! You made a mistake predicting pps .3, xxxxxl 09/19/14 06:49:13 PM
#108604   We were hoping for that amount, but we Rosym 09/19/14 04:37:40 PM
#108603   The facts are I was predicting .30 when Solantey 09/19/14 04:25:49 PM
#108602   I have not been around AMBS for long xxxxxl 09/19/14 03:30:33 PM
#108601   Not so sure about that. If you reverse xxxxxl 09/19/14 03:23:08 PM
#108600   Varying opinions is what creates a market. Solantey 09/19/14 03:15:22 PM
#108599   hahahahaha.. I believe the contrary. I believe people christjamin 09/19/14 03:01:37 PM
#108598   Unless Gerald has some substantial news on Monday Solantey 09/19/14 02:45:14 PM
#108597   Don't worry, it will go back up after hometownJOE 09/19/14 02:39:27 PM
#108594   That is exactly right, and his blog was joboggi 09/19/14 11:06:22 AM
#108593   With the current fundamentals and a market cap sumotrader 09/19/14 10:27:22 AM
#108592   Hope so! Trashboy 09/19/14 09:43:41 AM
#108591   At $.20 we are still only at $150 tsuguy 09/19/14 09:32:39 AM
#108590   I beg to disagree. Real CEOs are real christjamin 09/19/14 08:44:32 AM
#108589   interesting you should say JPetroInc 09/19/14 08:16:09 AM
#108588   You can believe whatever you want. But, you Rosym 09/19/14 07:43:28 AM
#108587   GC real CEO's don't blog, don't tweet and don el_lobodewallst 09/19/14 06:56:28 AM
#108585   This is no surprise. The pps is too joboggi 09/19/14 03:55:10 AM
#108584   Geralds Blog is a copy of the last sante1 09/19/14 12:28:20 AM
#108582   Looks like we're in for an exciting couple TekNerd 09/18/14 11:02:34 PM
#108581   Chairmans Blog...update.... Citrati 09/18/14 09:25:54 PM
#108579   The peeps calling for AMBS at .07 or sumotrader 09/18/14 07:47:21 PM
#108577   I checked on google on Amarantus BioScience that Rosym 09/18/14 04:35:09 PM
#108576   Or back above .09 for the record. This brharris 09/18/14 04:24:04 PM
#108575   I didnt put it there on purpose since dsw 09/18/14 04:17:32 PM
#108574   End of 2014 alone – will put us myersvodka 09/18/14 04:09:16 PM
#108573   We recognize that it is not optimal to Rosym 09/18/14 04:05:04 PM
#108571   However, if we do not believe we have dsw 09/18/14 03:49:09 PM
#108570   I disagree, he the one is giving us Rosym 09/18/14 03:36:12 PM
#108569   since i still think that GC should step Alapis 09/18/14 03:21:20 PM
#108567   Misinformation being propagated by short term focused investors Rosym 09/18/14 02:23:57 PM
PostSubject